ClinicalTrials.Veeva

Menu

Effect of Acupuncture on Quiescent Crohn's Disease

S

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Status

Completed

Conditions

Inflammatory Bowel Diseases
Crohn Disease

Treatments

Other: acupuncture
Other: Sham acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT04198831
ZYS2015-03

Details and patient eligibility

About

To observe the clinical effect of acupuncture on quiescent Crohn's disease

Full description

To observe the effect of acupuncture on maintaining remission of quiescent Crohn's disease

Enrollment

84 patients

Sex

All

Ages

16 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. aged 16-70;
  2. Patients with disease in remission: CDAI <150 and at least one of the following: serum C-reactive protein <5mg/L, fecal calprotectin <50μg/g or no ulcers on endoscopy;
  3. Patients with more than 2 disease relapses in the past year;
  4. patients were not taking medication or were only taking one or more of the following drugs: [prednisone ≤15mg/d, azathioprine (≤1mg/kg/d), methotrexate (≤15mg/w) or mesalazine (≤4g/d)] and prednisone was used for at least 1 month, while azathioprine, methotrexate or mesalazine was used for at least 3 months;
  5. those who did not use anti-TNF alpha and other agents within 3 months before entering the study;
  6. those who have never experienced acupuncture;
  7. patients signing informed consent.

Exclusion criteria

  1. patients who are recently pregnant or in pregnancy or lactation;
  2. patients with serious organic diseases;
  3. patients diagnosed as psychosis;
  4. patients who take antibiotics, probiotics, traditional Chinese medicine and other drugs at the same time, or who suffer from multiple diseases and need to take other drugs for a long time, and may affect the observation of the efficacy of this trial;
  5. severe skin diseases (such as erythema nodosum, pyoderma gangrenosum, etc.), eye diseases (such as iritis, uveitis, etc.), thromboembolic diseases and other serious extraintestinal manifestations;
  6. there are serious intestinal fistula, abdominal abscess, intestinal stenosis and obstruction, perianal abscess, gastrointestinal hemorrhage, intestinal perforation and other complications;
  7. patients with short bowel syndrome who have undergone abdominal or gastrointestinal surgery in the past half a year;
  8. there are skin diseases or defects in the selected area of acupuncture and moxibustion that cannot be performed.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

84 participants in 2 patient groups

acupuncture group
Experimental group
Description:
Receiving acupuncture and moxibustion treatment
Treatment:
Other: acupuncture
sham acupuncture group
Sham Comparator group
Description:
Receiving sham acupuncture and sham moxibustion treatment
Treatment:
Other: Sham acupuncture

Trial contacts and locations

1

Loading...

Central trial contact

Chunhui Bao, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems